+ -dependent oxidation of betaine aldehyde to its corresponding acid, the osmoprotector glycine betaine. This reaction is involved in the catabolism of choline and in the response of this important pathogen to the osmotic and oxidative stresses prevalent in infection sites. The crystal structure of PaBADH in complex with NADPH showed a novel covalent adduct between the C2N of the pyridine ring and the sulfur atom of the catalytic cysteine residue, Cys 286 . This kind of adduct has not been reported previously either for a cysteine residue or for a low-molecular-mass thiol. The Michael addition of the cysteine thiolate in the 'resting' conformation to the double bond of the α,β-unsaturated nicotinamide is facilitated by the particular conformation of NADPH in the active site of PaBADH (also observed in the crystal structure of the Cys286Ala mutant) and by an ordered water molecule hydrogen bonded to the carboxamide group. Reversible formation of NAD(P)H-Cys 286 adducts in solution causes reversible enzyme inactivation as well as the loss of Cys 286 reactivity towards thiolspecific reagents. This novel covalent modification may provide a physiologically relevant regulatory mechanism of the irreversible PaBADH-catalysed reaction, preventing deleterious decreases in the intracellular NAD(P) + /NAD(P)H ratios.
INTRODUCTION
Pseudomonas aeruginosa is one of the most important bacterial pathogens in plants, animals and humans. This Gram-negative bacterium has an outstanding ability to grow in an extensive variety of organic compounds and habitats, seeming to be practically ubiquitous [1] , and exhibits great resistance to stress conditions and antibiotics [2] . P. aeruginosa cells can grow in choline as their only carbon and nitrogen source [3] , which is significant because the tissues infected are rich in choline or choline precursors [4, 5] that are converted into choline by enzymes secreted by the bacterium [6] . The second step in the catabolism of choline in several bacteria, including P. aeruginosa, is the irreversible NAD(P)
+ -dependent oxidation of betaine aldehyde to glycine betaine catalysed by BADH (betaine aldehyde dehydrogenase) [7, 8] . Glycine betaine is a widely distributed and very efficient osmoprotectant [9] , which acts as such in P. aeruginosa cells growing in the hyperosmotic environment of infected tissues [10, 11] . In addition, PaBADH (P. aeruginosa BADH) is one of the few aldehyde dehydrogenases that can use NADP + with similar efficiency to NAD + [12] , a property that can be used by the bacterium to produce the NADPH needed to combat the oxidative stress imposed by the host defences [13] . Thus PaBADH might be crucial for the bacterium in its mechanisms of defence against the osmotic and oxidative stresses prevalent in infected tissues, and appears to be a potential target for antimicrobial agents because, in addition, its inhibition would lead to the accumulation of betaine aldehyde, which is highly toxic [8, 14] .
The reaction mechanism of the hydrolytic ALDHs (aldehyde dehydrogenases) involves three chemical steps [15] : (1) the nucleophilic attack of the catalytic cysteine residue (Cys 286 in the case of PaBADH) on the aldehyde substrate, resulting in formation of a hemithioacetal intermediate [Enz-S-CH-(OH)-R]; (2) the transfer of the hydride from the hemithioacetal to NAD(P) + , resulting in formation of a thioester intermediate (Enz-S-CO-R); and (3) the nucleophilic attack of a water molecule on the thioester intermediate, leading to the release of the carboxylic acid product. Glycine betaine is not a physiologically relevant inhibitor of the irreversible reaction catalysed by PaBADH [12] , which is negatively regulated only by the other reaction product, the reduced nucleotide. Since the kinetic mechanism of most ALDHs is steady-state bi-bi ordered, with NAD(P)
+ being the first substrate to add to the enzyme and NAD(P)H the last product to be released, NADP(H) behaves as a competitive inhibitor against NADP + (reviewed in [16] ). However, in PaBADH and other BADHs [12, 17, 18] , as well as in ALDH3 [19] , a mixed inhibition was observed, which has not yet been satisfactorily explained in mechanistic or structural terms.
Data from crystallographic [20] and NMR [21] studies indicate that there is substantial conformational flexibility of the nicotinamide half of the cofactor bound to ALDH enzymes, and that this conformational flexibility is crucial for catalysis. The oxidized cofactors, NAD(P) + , have been observed bound into the active site in an extended conformation that allows the oxidation of the substrate [the HT (hydride transfer) conformation], whereas the bound reduced cofactors, NAD(P)H, were found in several different folded conformations [the Hyd (hydrolysis) conformations] that allow the hydrolytic step of the reaction (reviewed in [16] ). On the other hand, slow conformational changes of the PaBADH protein induced by the binding of the nucleotides were proposed to occur as an explanation of the progressive loss of reactivity of the catalytic cysteine residue towards MMTS (methanethiosulfonate) when the enzyme was pre-incubated in the presence of NAD(P) + or NAD(P)H [22] . The three-dimensional crystal structures of ALDH enzymes so far obtained in complex with nucleotides, however, do not show major conformational changes with respect to the apoenzyme forms.
To further our understanding of the structural and functional properties of PaBADH, in particular of the role of the reduced nucleotide in the regulation of the enzyme activity, we determined the crystal structures of the wild-type and of the Cys286Ala mutant enzymes in complex with NADPH. Both structures reveal a conformation of the reduced nucleotide different from those so far observed in other ALDH crystal structures, a novel covalent adduct between the NADPH pyridine ring and the sulfur atom of Cys 286 in the wild-type enzyme. This adduct also forms in solution, causing both a reversible enzyme inactivation, which may have important regulatory implications, and the previously found loss of reactivity of Cys 286 towards thiol-specific reagents [22] .
EXPERIMENTAL Expression, purification and activity assay of PaBADH
Previously described procedures were used for the expression of wild-type PaBADH and the Cys286Ala mutant in Escherichia coli cells [8] . The enzymes were purified to homogeneity as described previously [23] and did not contain bound NAD(P) + or NAD(P)H as judged by the A 280 /A 260 ratio, which was ∼2.0. The dehydrogenase activity of the wild-type enzyme was assayed spectrophotometrically at 30 • C, by monitoring the increase in A 340 in a mixture (0.5 ml) consisting of 1 mM EDTA, 1 mM betaine aldehyde and 1 mM NADP + or 2 mM NAD + in 100 mM potassium phosphate buffer, pH 7.5 (standard assay). All assays were initiated by addition of the enzyme (4.0-8.5 nM active sites). Initial rates were determined from the initial linear portions of reaction-progress curves.
Crystallization conditions and data collection
Wild-type PaBADH and the Cys286Ala mutant were concentrated to 20 mg/ml in an Amicon Ultra-4 centrifugal filter unit (Millipore) and dialysed exhaustively against 10 mM potassium phosphate buffer, pH 6.9, containing 0.2 mM EDTA, 200 mM KCl, 1 % (v/v) glycerol and 5 mM dithiothreitol. Hanging-drop trays were prepared in 85 mM Hepes/NaOH buffer, pH 7.5, 8.5 % (v/v) propan-2-ol, 17 % (w/v) PEG 4000 [PEG is poly(ethylene glycol)] and 15 % (v/v) glycerol, as described previously [24] inside a glove box filled with nitrogen. NADPH (2 mM final concentration) was added to the enzyme preparation prior to crystallization. Diffraction data of the wild-type enzyme were collected at 100 K at the SER-CAT Access Team beamline 22-ID of the APS (Advanced Photon Source), Argonne National Laboratory (Argonne, IL, U.S.A.), using a MAR Mosaic MX-300 detector. Diffraction data of the Cys286Ala mutant were collected at 100 K at the X6a beamline at the National Synchrotron Light Source (Upton, NY, U.S.A.) using a ADSC Q270 CCD (charge-coupled device) detector. Data from the wild-type enzyme crystal were auto-indexed and integrated using MOSFLM [25] , and scaled and truncated with Scala [26] . The Cys286Ala data were auto-indexed, integrated and scaled using HKL2000 [27] .
Structure solution and refinement
Diffraction phases for wild-type and Cys286Ala mutant PaBADHs were determined by molecular replacement with the program Phaser [28] using the PaBADH co-ordinates with the structure given under PDB code 2WME [24] as a starting model. Alternating cycles of automatic and manual refinement were carried out with the standard protocols of Phenix software [29] . We initially used non-crystallographic symmetry restraints, which were later removed. Phenix was also used for atomic positions, atomic displacement parameters, and translation, libration and TLS (translation-libration-screw) refinement calculations. The program Coot [30] was used to analyse the electron density maps (2F o − F c and F o − F c ). Water molecules were automatically localized using Phenix [29] and Coot [30] . Structural alignments were performed with the programs Coot [30] and CCP4mg [31] . Figures were created with PyMOL (http://www.pymol.org/) and CCP4mg [31] .
DFT (density functional theory) calculations
The initial structure of a NADPH-cysteine adduct was built from standard fragments and energy-minimized using PC Spartan 06 software (Wavefunction). A search for the most abundant conformer was performed by MM (molecular mechanics) methods using the MMF94 Conformer Distribution Module of the PC Spartan 06 software package. The exploration of the rotation angle was set to 30
• as a limit. The geometry of this conformer was fully optimized by DFT calculations at the B3LYP/6-31G* level.
Inactivation of PaBADH with NAD(P)H and thiol-specific reagents
Wild-type enzyme (3.75 μM active sites) was incubated with different concentrations of NAD(P)H at 25
• C in 10 mM potassium phosphate buffer, pH 7.5, containing 250 mM KCl, 1 mM EDTA and 10 % (v/v) glycerol (Buffer A). The remaining enzyme activity was measured in aliquots taken at the indicated times, under the same conditions of the standard assay but using 0.05 mM NAD(P) + and 0.25 mM betaine aldehyde, and in the presence of the same NAD(P)H concentration as that used in the incubation. The effect of the reduced nucleotides on PaBADH inactivation by IAM (iodoacetamide) was investigated by incubating enzyme samples, which had been previously depleted of 2-mercaptoethanol by gel filtration using Buffer A saturated with nitrogen gas, with the reduced nucleotides as described above for 2 h prior to adding the thiol-modifying reagent. Then, aliquots were taken from the incubation mixtures at appropriate time intervals for the measurement of the remaining enzyme activity, using the standard assay with no reduced nucleotide added. The thiol-specific reagent and the nucleotides were dissolved in nitrogen-saturated water; incubations were carried out anaerobically. First-order analyses of the time courses of inactivation were performed using single exponential equations and non-linear regression calculations. According to the kinetic mechanism proposed for adduct formation (see Scheme 1), the first-order rate constants of formation and breakage of the adduct (k + 2 and k − 2 respectively) were estimated by re-plotting the observed first-order inactivation constant (k obs ) against NADPH concentration, and fitting the data to eqn (1):
where
.
RESULTS

Overall crystal structure of the wild-type and Cys286Ala mutant PaBADHs complexed with NADPH
The structures of the NADPH complexes of the recombinant wildtype PaBADH and of the Cys286Ala mutant have been determined at 2.30 and 2.45 Å resolution respectively (1 Å = 0.1 nm). The crystals belong to the P3 2 21 space group and contain four subunits in the asymmetric unit describing one tetramer, which corresponds to the biological unit of the enzyme [33] and show the catalytic, nucleotide binding and oligomerization domains characteristic of ALDH folding [34] . For the two structures, the TLS refinement of the crystallographic data improved the statistics of the refinement, stressing the existence of a dynamic component in the PaBADH structure. The intra-and inter-subunit K + ions found in the PaBADH-NADP + crystal [24] were also observed in these two PaBADH-NADPH crystals. All data collection and refinement statistics are summarized in Table 1 .
Novel NADPH-cysteine adduct
In the four subunits of the asymmetric unit of the wild-type PaBADH-NADPH crystal structure, the electron density map shows the C2N of the pyridine ring at covalent bond distances (1.75, 1.50, 1.66, and 1.57 Å in subunits A, B, C and D respectively) of the sulfur of Cys 286 , indicating the formation of NADPH-cysteine adduct, so far not reported in any ALDH. Neither, to the best of our knowledge, has it been reported that a covalent adduct of this type forms between NAD(P)H and a cysteine residue of other enzymes, or between NAD(P)H and a low-molecular-mass thiol. In order to avoid a bias of the model over the phases, and to confirm the existence of electron density for the complete NADPH molecule, a simulated annealing omit map of the neighbouring region was calculated ( Figure 1A ). the NADPH-thiol adduct and of the attached ribose ring are twisted half-chair and C2 -endo envelope respectively. These are the conformations that best fit into the F o − F c omit map of the PaBADH crystal, as shown in Figure 1 (A). The deviation of the 1,2,3,4-tetrahydropyridine twisted half-chair of the NADPH-cysteine adduct from a planar ring conformation can be described by the angle between the planes defined by C2N-N1N-C6N and C2N-C3N-C4N (α N , 125
• ), and the angle between the planes defined by C2N-C4N-C5N and C2N-C3N-C4N (α C , 137
• ) ( Figure 1C ). The carboxamide group, which is not constrained in the plane of the pyridine ring by conjugation as it is in NADP + , can rotate freely; this is probably the reason for the poor density attached to it in the crystal. After several refinement cycles, a position of the carboxamide that does not produce any steric clash with the atoms in the active site is that shown in Figure 1 and described by the dihedral angle C2N-C3N-C7N-N7N of − 125 o . The twisted half-chair conformation of the 1,2,3,4-tetrahydropyridine is clearly different from the planar pyridine ring of the oxidized nucleotide and from the almost planar conformation of the dihydropyridine ring of the reduced nucleotide so far observed in ALDH enzymes. It is, however, similar to the half-chair conformation found in other tetrahydropyridine rings resulting from alkylation at C5N or C6N [35] . The electronic density and the high B-factor values, particularly those of C3N and C2N and of the sulfur of the catalytic cysteine residue, suggest that the tetrahydropyridine ring can exist in another half-chair conformation where the C3N has two opposite elevation angles with respect to C2N. Indeed, DFT calculations indicate that this alternative conformation has similar stability in a L-cysteine-NAD(P)H adduct, but in the PaBADH active site this conformation would be less stable due to steric constraints.
The electron density data show that the carboxamide group and the catalytic cysteine residue have a cis relation, i.e. the carboxamide group is oriented equatorially and the cysteine residue is oriented axially. Because of this, the nucleophilic attack takes place on the re face of the dihydropyridine ring. Given the architecture of the active site of the ALDHs, only when the catalytic cysteine residue is in one of the two conformations observed in the ALDH crystals (the one we called the 'resting' conformation [24] because its sulfur atom is far from the carbonyl C atom of the bound aldehyde) is the thiol group positioned to perform the nucleophilic attack on the reactive C atom of the dihydropyridine ring, the C2N. The occupancy of the nucleotide (0.6-0.8) corresponds to that of the catalytic cysteine in the 'resting' conformation (0.7-1.0). In subunits B, C and D, a small proportion of this residue was observed in the 'attacking' conformation (thus named [24] because the sulfur atom is in the correct position to perform the nucleophilic attack on the aldehyde), not forming the covalent adduct with NADPH.
Conformations of NADPH inside the PaBADH active site
The crystal structures of the wild-type and mutant Cys286Ala PaBADH enzymes in complex with NADPH show the complete nucleotide in every subunit. In the two enzymes, the adenosine moiety of the NADPH molecules makes essentially the same interactions with the enzyme (Figures 2A and 2B and Supplementary Tables S1 and S2 at http://www.BiochemJ.org/bj/439/bj4390443add.htm) as those found in the PaBADH-NADP + crystal [24] . The nicotinamide moiety, however, was found in two different hydrolysis conformations not observed previously in any ALDH enzyme. In one of them (observed in every subunit of the two enzymes) the reduced nicotinamide was in a position deeper inside the active site than in those Hyd conformations observed in crystals of other ALDHs with NAD(P)H bound, and closer to the HT conformation of NAD(P) + ( Figure 2C ). Because of this, we call this conformation the Hyd 1 . The N1N of the reduced nicotinamide in the Hyd 1 conformation observed in the Cys286Ala PaBADH mutant is rotated around 7
• and displaced only by approximately 1 Å (ranging from 0.63 to 1.06 Å in the different subunits) with respect to the position of the same atom in the oxidized nicotinamide in the HT conformation found in ALDH2 [20] . In the wild-type enzyme, this displacement is even smaller (ranging from 0.46 to 0.88 Å), but the rotation is 19
• . These differences are probably due to the formation of the covalent adduct between the reduced nicotinamide and the catalytic cysteine in the wild-type enzyme. It is not surprising that the interactions of the reduced nicotinamide of NADPH in the Hyd 1 conformation with PaBADH ( Figure 2A and Supplementary Table S1 ) are similar to those of the oxidized nicotinamide of NAD(P) + in the HT conformation observed in other known crystal structures of ALDH enzymes [36] . But different from the known holo ALDH structures, either with NAD(P) + or NAD(P)H, the N7N or O7N of the reduced nucleotide are at hydrogen bond distances from a glycerol hydroxy group ( Figure 2D ), which occupies the same position as the putative hydrolytic water molecule [37] observed in the PaBADH-NADP + crystal [24] . This hydroxy group is also at a hydrogen bond distance from the OE1 of the catalytic residue Glu 252 (Glu 268 in ALDH2), which is the general base involved in activation of the hydrolytic water molecule. Only in subunit A of the wild-type enzyme does the carboxamide group not make these interactions, because rotations of the pyridine ring and of the carboxamide group place the O7N and 7N7 inside the oxyanion hole (Supplementary Figure S1 at http://www.BiochemJ.org/bj/439/bj4390443add.htm).
The other novel NADPH conformation, hereafter called Hyd n , was observed only in subunit C of the wild-type enzyme, with an occupancy of 0.3 ( Figure 2B ). In this conformation, the nucleotide is folded so that the nicotinamide phosphate interacts with the adenine ribose, and the nicotinamide ribose interacts with the adenine ring and Arg 210 ( Figure 2B and Supplementary Table S2 ). Although there is no electronic density for the nicotinamide ring in this conformation, most probably due to a very high flexibility, the rest of the NADPH molecule has a similar conformation to that adopted by free NADPH in solution, as indicated by DFT calculations (results not shown). This conformation appears, therefore, to be either the last one adopted by the bound NADPH on its way out of the active site or the first one adopted on its way into the active site.
In every subunit of the Cys286Ala mutant we also found a third conformation of NADPH (not shown) with occupancies ranging from 0.3 to 0.5. This conformation is similar to those called by us Hyd 2 (see Figure 2C ), which were observed in other ALDHs (e.g. PDB code 1O00) [20] . An ensemble of several NAD(P)H conformations found so far in the active site of ALDH enzymes, including the two novel ones reported in the present study, constitute a series of snapshots of the trajectory followed by the reduced nucleotide when entering or leaving the active site, as shown in Supplementary Movies S1 and S2 at http://www.BiochemJ.org/bj/439/bj4390443add.htm. In PaBADH, Hyd 1 and Hyd n would be the initial or last conformations.
Formation of NAD(P)H-Cys 286 adducts in solution
Formation of NAD(P)H adducts with the catalytic cysteine residue, as the one observed in the PaBADH crystal structure, should cause enzyme inactivation by preventing the formation of the first intermediate of the reaction, the hemithioacetal. Therefore, to investigate the ability of PaBADH to form cysteine-NAD(P)H adducts in solution, we pre-incubated the enzyme with the reduced nucleotides in the absence of substrate aldehyde as described in the Experimental section, and measured the remaining enzyme activity at different times in assay medium containing subsaturating concentrations of the substrates and the reduced nucleotide concentration used in the pre-incubation. Both NADPH and NADH cause a progressive loss of PaBADH activity that is time-and concentration-dependent, follows pseudofirst-order kinetics and reaches a plateau ( Figure 3A) . The highest concentration of the reduced nucleotides used in these experiments (200 μM) is subsaturating, particularly in the case of NADH [12] , but we could not use higher concentrations because of interference with the spectrophotometric enzyme assay. The rate constant of inactivation by NADH is lower than that obtained with the same concentration of NADPH ( Figure 3B ), congruously with the lower degree of saturation of the enzyme by NADH. The observed inactivation rate constants (k obs ) increased hyperbolically in response to increased nucleotide concentrations ( Figure 3A , inset), consistent with a reversible process that consists at least of two steps: the rapid reversible binding of the nucleotides to the enzyme followed by a slower and also reversible intramolecular change that leads to inactive enzyme forms (Scheme 1). Eqn (1) of the Experimental section, derived for this mechanism, allowed the estimation of values for the first-order rate constants of formation (k + 2 , 0.169 min − 1 ) and breakage (k -2 , 0.031 min − 1 ) of the PaBADH-NADPH adduct, as well as of the equilibrium constant (k + 2 /k − 2 ). The reversible nature of adduct formation was confirmed by the total reactivation of the NAD(P)H-modified enzyme by removal of NADPH by gel filtration, or by the 500-fold dilution into the assay medium when the reduced nucleotide was not included (results not shown). NAD(P) + can reverse the enzyme inactivation caused by NAD(P)H, as proved by the recovery of activity observed when the assays were performed at high, saturating, NAD(P) + concentrations (results not shown).
To confirm that the observed NAD(P)H-induced enzyme inactivation was due to formation of NAD(P)H-Cys 286 adducts, in the present study we followed the kinetics of inactivation by IAM of PaBADH samples that had been previously incubated with 0.05 NADPH or with 0.2 mM NAD(P)H until the remaining activity reached a plateau (120 min). Enzyme activity assays in these experiments were performed in the absence of NAD(P)H and at high substrate concentration, to allow for the full reactivation Figure) are the same as those of the Hyd 1 conformation shown in panel (A). The nicotinamide ring has no associated electron density. For comparison, the nicotinamide moiety in the Hyd 1 conformation, observed in the same subunit with 0.7 occupancy, is also shown. The two conformations of the catalytic cysteine residue are denoted by "r" (resting) and "a" (attacking). PaBADH residues and the NADPH molecule are shown as sticks with carbon atoms in grey (light grey for protein, dark grey for NADPH in the Hyd 1 conformation), and oxygen and sulfur atoms in red and yellow respectively. Hydrogen bonds (cut-off 3. of the enzyme inactivated by the reduced nucleotide so that only the inactivation caused by IAM was followed. As shown in Figure 3(C) , the protection against inactivation by the thiolspecific reagent afforded by a given NAD(P)H concentration correlates with the extent of enzyme inactivation achieved by the same nucleotide concentration. The level of protection provided by NADPH was higher that that afforded by NADH, again consistent with the higher affinity of the enzyme for the former. The degree of protection was less than that of inactivation, probable due to a partial dissociation of the adduct favoured by the reaction of the thiol reagent with the free enzyme thiolate that exists in equilibrium with the adduct.
448Á. G. Díaz-Sánchez and others
An adduct between the sulfur atom of the catalytic cysteine residue and the pyridine ring of NADP + was observed in the crystal structure of FDH (10-formyltetrahydrofolate dehydrogenase) [38] . On the basis of QM (quantum mechanics)/MM calculations, an NAD-catalytic cysteine adduct was predicted to also form in ALDH2 [39] . We found that Cys 286 also forms adducts with NAD(P) + , as indicated by the peak at 325 nm observed in the UV absorption difference spectra of NAD(P) + (Supplementary Figure S2 at http://www.BiochemJ. org/bj/439/bj4390443add.htm), which was absent in the difference spectrum of the Cys286Ala mutant (results not shown). This peak is within the wavelength range of 310-345 nm where similar peaks have been found for NAD(P)
+ adducts with thiol groups [38, 40, 41] . Pre-incubation with NAD(P) + , however, does not result in activity losses because the NAD(P) + -cysteine adducts are readily reversible in the presence of the aldehyde substrate of the ALDH reaction [38] , as shown in Scheme 1.
The previously observed loss of reactivity of the catalytic cysteine residue towards a thiol-specific reagent, MMTS, when PaBADH was pre-incubated in the presence of NAD(P) + or NAD(P)H [22] was explained by a slow conformational change (of unknown nature) of the enzyme upon binding the nucleotides. The ability of Cys 286 to form adducts with the oxidized and reduced nucleotides reported here provides an alternative satisfactory explanation to those results. The nucleotides produce a chemical change in the enzyme, not a conformational one as previously proposed [22] . In that study inactivation by NAD(P)H following incubation with the enzyme was not detected because the activity assays were performed in the absence of the reduced nucleotides at high substrate concentration, thus allowing for a fast enzyme reactivation.
DISCUSSION
Mechanisms of formation of NAD(P)H-cysteine and NAD(P)-cysteine adducts
The crystallographic evidence indicating that an adduct is formed between the sulfur of the catalytic cysteine residue of PaBADH and the C2N of the dihydropyridine ring is fully consistent with Michael addition of the thiolate to the double bond of the α,β-unsaturated nicotinamide. We propose a mechanism (Scheme 2A) that involves an initial nucleophilic attack of the conjugate base of the cysteine residue (the thiolate) at the 2-position of the 1,2-dihydropyridine ring (I), forming an unstable oxyanion intermediate (II). Then, the oxyanion removes a proton from a water molecule to give an enol intermediate (III), which readily and irreversibly tautomerizes to the 1,2,3,4-tetrahydropyridine derivative (IV). It is clear that the 1,2,3,4-tetrahydropyridine derivative cannot be formed by exposure of the crystal to the high-energy X-rays of the synchrotron during the diffraction process. If reduction of the dihydropyridine ring of NADPH to a 1,2,3,4-tetrahydropyridine ring took place under these conditions, which has not been observed before, it would result in a nonreactive pyridine unable to form the adduct with the catalytic cysteine residue.
The slow, rate-limiting, step in the mechanism is most probably the thiolate attack on the C2N, as is usually the case in nucleophilic additions [41] . In the case of the NAD(P(H))-cysteine adducts, the nucleophilic attack is favoured by the high polarization of + (VI), producing, by a nucleophilic addition, a 1,4-dihydropyridine ring derivative (VII), the NAD(P)-cysteine adduct, which may readily dissociate by an elimination reaction.
the electronic density of C2N promoted by the carboxamide carbonyl conjugation at this position. Additionally, in the active site of PaBADH this step is greatly favoured by the hydrogen bond formed between the carbonyl oxygen atom of the NADPH carboxamide group and an ordered water molecule observed in the PaBADH-NADP + crystal [24] in a similar position to a hydroxy group of a glycerol molecule observed in the wild-type and mutant Cys286Ala PaBADH-NADPH crystals ( Figure 2D ). This interaction would: (i) polarize the carbonyl group, thus making the double bond between C2N and C3N more susceptible to the nucleophilic attack on C2N; (ii) stabilize the oxyanion formed after the nucleophilic addition; and (iii) allow for protonation of the oxyanion intermediate, leading to formation of a stable NAD(P)H-cysteine adduct, the 1,2,3,4-tetrahydropyridine derivative.
Even though the last step in the formation of the 1,2,3,4-tetrahydropyridine derivative is irreversible, the NAD(P)H-Cys 286 adduct dissociates by formation of an iminium cation via the elimination of the cysteinyl residue promoted by the vicinal nitrogen atom of the pyridine ring. In the spatial arrangement of the pyridine ring observed in the PaBADH crystal structure (the twisted half-chair), the nitrogen lone electron pair has an antiplanar orientation with respect to the sulfur atom, thus promoting the elimination of the cysteine residue, i.e. the formation of the free thiolate and of a NAD(P)H iminium derivative (V), which can experience a tautomeric equilibrium imine-enamine (Scheme 2A). Given the acidic nature of the proton at the C3N position, the enamine, i.e. NAD(P)H, is highly favoured in this equilibrium.
Regarding the NAD(P)-catalytic cysteine adducts, these form in a nucleophilic addition reaction where the thiolate group performs a nucleophilic attack on the C4N of the pyridine ring of NAD(P) + (Scheme 2B, VI), producing the 1,4-dihydropyridine ring derivative (VII) observed in the crystal structure of 10-formyltetrahydrofolate dehydrogenase [38] . These kinds of adducts can readily dissociate via an elimination reaction [42] .
NADPH conformation
NAD(P)H adducts can only be formed by nucleophilic attack on pyridine ring carbon atoms that are making double bonds, such as C2N, C5N or C6N. In PaBADH, because of the manner in which the reduced pyridine ring binds into the active site (the Hyd 1 conformation), the electrophilic carbon atom susceptible to attack by the catalytic cysteine residue is C2N, and only the resting conformation of the catalytic cysteine has the appropriate distance and angle of attack for forming the adduct, as found in the PaBADH-NADPH crystal structure reported in the present study. Although the binding of the nicotinamide into the active site is incompatible with the cysteine residue in the resting conformation because of the steric clash between the pyridine ring and the thiol group, NAD(P)H molecules can form an adduct with the catalytic cysteine in the resting conformation when they enter the active site and their C2N clashes with the sulfur atom.
The similarities between the Hyd 1 conformation of the reduced nucleotide observed inside the active site of PaBADH and the conformation adopted in the active site of ALDHs by the oxidized nucleotide (the HT conformation) might suggest that in the PaBADH crystal there is an NADP + molecule instead of NADPH. It is known that the reduced pyridine nucleotides can be spontaneously oxidized, but oxidation of our crystals is highly improbable because they were grown under anaerobic conditions. That the observed conformation corresponds to NADPH and not to NADP + is strongly supported by: (i) the small but significant displacement of the reduced pyridine ring with respect to the position of the oxidized one, which occupies an almost invariable position in every ALDH crystal, the position needed c The Authors Journal compilation c 2011 Biochemical Society for an efficient hydride transfer; (ii) the formation of the adduct at the C2N, which is the electrophilic centre in the dihydropyridine ring, whereas C4N is the electrophilic centre in the oxidized pyridine ring; (iii) the non-planar structure of the pyridine ring, which would be planar if it were NADP + even in the case that this nucleotide formed an adduct with the catalytic cysteine, as observed in the FDH [38] ; (iv) the high mobility of the carboxamide group, which in the tetrahydropyridine derivative may rotate freely, as in NADPH, whereas in NAD(P)
+ it is constrained in the plane of the ring by conjugation; and (v) the catalytic cysteine conformation, which is the resting one as needed for the attack on the C2N of NADPH and not the conformation intermediate between the resting and attacking needed for the attack on the C4N of NADP + [38] . To demonstrate that the Hyd 1 conformation of NADPH observed in the wild-type PaBADH does not result from adduct formation but that, on the contrary, adduct formation is facilitated by the nucleotide adopting this particular conformation, we obtained the crystal structure of the Cys286Ala mutant in complex with NADPH. Crystals of both the wild-type and the mutant enzymes had the same space group, which allows an accurate structural comparison between them. The same conformation of the reduced nucleotide was observed in all subunits of the asymmetric unit of the Cys286Ala crystal, in which the adduct is obviously absent. This finding is clear evidence of the ability of the reduced nucleotide to adopt the Hyd 1 conformation inside the PaBADH active site. Moreover, after running a non-rigid docking of the NADH molecule into the PaBADH active site using the PatchDock server [43] , the only resulting NADH conformation in which the nicotinamide was inside the active site was very similar [with a RMSD (root mean square deviation) of 0.11 Å] to the Hyd 1 conformation observed in the Cys286Ala mutant (results not shown).
Implications of the cysteine-NAD(P)H adduct formation
The significant decreases in the Cys 286 reactivity resulting from formation of adducts with NAD(P)H may protect the catalytic cysteine residue against oxidation (as pointed out by others in the case of the NAD(P)-catalytic cysteine adducts [39] ), thus preventing irreversible enzyme inactivation. However, the catalytic NAD(P)H-Cys adducts may also play a regulatory role of predictable physiological relevance. This is because this covalent modification of the thiol group is reversible and would be of great help in slowing down an irreversible reaction (such as the one catalysed by ALDH enzymes) before this reaction could significantly decrease the intracellular NAD(P) + /NADPH ratio with adverse consequences. In the reaction catalysed by the ALDH enzymes, the acid product is a very poor inhibitor so that the negative control of the reaction rate is mainly by NAD(P)H inhibition. PaBADH has a low affinity for the reduced nucleotides as assessed by their competitive inhibition constant, (K ic ) values, 182 and 1075 μM for NADPH and NADH respectively [12] . These values are considerably higher than those of the NAD(P) + dissociation constant (K ia ), which are 48 and 186 μM for NADP + and NAD + respectively [12] , making the reduced nucleotides, particularly NADH, poor inhibitors of the PaBADH reaction in their physiological range of concentrations. The reversible inactivation of the enzyme by NAD(P)H notably increases its sensitivity to decreases in the NAD(P) + /NAD(P)H ratios and therefore allows for a finer tuning of the PaBADH activity to the intracellular redox conditions. Thus formation of the NAD(P)H-Cys 286 adducts may constitute an efficient mechanism by which PaBADH activity can be transitorily decreased if it is higher than the activities of the NAD(P)H-utilizing enzymes, thus allowing time for the recycling of the oxidized nucleotide. Given the reversibility of the catalytic cysteine-NAD(P)H adducts, the PaBADH activity can be re-assumed when the NAD(P)H concentrations go down and the NAD(P) + concentrations go up to normal values.
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